Tuesday , November 21 2017
Home / Resources / Products / BD’s New Infusion Set with FlowSmart Technology

BD’s New Infusion Set with FlowSmart Technology

BD has received FDA clearance for its new insulin pump infusion set with FlowSmart technology. The new set uses a novel catheter which allows insulin to flow out of two places: the bottom (like current infusion sets) and the side (a new innovation). the new tech innovation led to an ~80% reduction in flow interruptions and a ~78% reduction in occlusion events. This should help patients avoid silent occlusions, which are often not detected by pumps and can lead to unexplained hyperglycemia. Features include: tubing lengths of both 24 and 42 inches; the smallest infusion set insertion needle with a 30-gauge needle; BD’s patented sliding shield which covers the needle even after insertion; and a multi-position connector that allows patients to connect the tubing to the on-body set in eight different positions (e.g., no need to line it up).